Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target |
Mechanism CD79B inhibitors(B-cell antigen receptor complex-associated protein beta chain inhibitors), Tubulin inhibitors, Apoptosis stimulants + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Araris Biotech AGStartup |
Active Organization Araris Biotech AGStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC39H67N5O7 |
InChIKeyDASWEROEPLKSEI-UIJRFTGLSA-N |
CAS Registry474645-27-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CH | Araris Biotech AGStartup | 01 Jul 2021 |